Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2309 ARTÍCULOS , VIENDO DEL 421 AL 435

Dysbiosis and Alzheimer's disease: role of probiotics, prebiotics and synbiotics

Thakkar A, Vora A, Kaur G, Akhtar J.

Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):2911-2923. doi: 10.1007/s00210-023-02554-x. Epub 2023 Jun 7.

Association between pseudoexfoliation and Alzheimer's disease-related brain atrophy

Jeong WC, Min JY, Kang TG, Bae H.

PLoS One. 2023 Jun 8;18(6):e0286727. doi: 10.1371/journal.pone.0286727. eCollection 2023.

CRISPR-Cas9 in Alzheimer's disease: Therapeutic trends, modalities, and challenges

Chacko L, Chaudhary A, Singh B, Dewanjee S, Kandimalla R.

Drug Discov Today. 2023 Aug;28(8):103652. doi: 10.1016/j.drudis.2023.103652. Epub 2023 Jun 7.

Targeting α7 nicotinic acetylcholine receptors and their protein interactions in Alzheimer's disease drug development

Burns LH, Pei Z, Wang HY.

Drug Dev Res. 2023 Sep;84(6):1085-1095. doi: 10.1002/ddr.22085. Epub 2023 Jun 8.

Memantine induced encephalopathy in chronic kidney disease: a case report

Prasad P, Bagai S, Khullar D.

Postgrad Med J. 2023 Jun 8;99(1171):498-499. doi: 10.1136/postgradmedj-2022-141646.

Implications of the Approval of Lecanemab for Alzheimer Disease Patient Care: Incremental Step or Paradigm Shift?

Knopman DS, Hershey L.

Neurology. 2023 Oct 3;101(14):610-620. doi: 10.1212/WNL.0000000000207438. Epub 2023 Jun 9.

Cognitive Deficits in Aging Related to Changes in Basal Forebrain Neuronal Activity

Chaves-Coira I, García-Magro N, Zegarra-Valdivia J, Torres-Alemán I, Núñez Á.

Cells. 2023 May 25;12(11):1477. doi: 10.3390/cells12111477.

Treponema denticola Has the Potential to Cause Neurodegeneration in the Midbrain via the Periodontal Route of Infection-Narrative Review

Pisani F, Pisani V, Arcangeli F, Harding A, Singhrao SK.

Int J Environ Res Public Health. 2023 Jun 4;20(11):6049. doi: 10.3390/ijerph20116049.

Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer's Disease

Su M, Nizamutdinov D, Liu H, Huang JH.

Int J Mol Sci. 2023 May 25;24(11):9272. doi: 10.3390/ijms24119272.

Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status

Pinzi L, Bisi N, Sorbi C, Franchini S, Tonali N, Rastelli G.

Molecules. 2023 Jun 4;28(11):4544. doi: 10.3390/molecules28114544.

Insights into prevention mechanisms of bioactive components from healthy diets against Alzheimer's disease

Wang J, Yu Z, Peng Y, Xu B.

J Nutr Biochem. 2023 Sep;119:109397. doi: 10.1016/j.jnutbio.2023.109397. Epub 2023 Jun 8.

TREM2, microglial and ischemic stroke

Wang H, Li X, Wang Q, Ma J, Gao X, Wang M.

J Neuroimmunol. 2023 Aug 15;381:578108. doi: 10.1016/j.jneuroim.2023.578108. Epub 2023 May 16.

Advances of computer-aided drug design (CADD) in the development of anti-Azheimer's-disease drugs

Niu Y, Lin P.

Drug Discov Today. 2023 Aug;28(8):103665. doi: 10.1016/j.drudis.2023.103665. Epub 2023 Jun 9.

Animal models of Alzheimer's disease: An originof innovativetreatments and insight to the disease's etiology

Chavan RS, Supalkar KV, Sadar SS, Vyawahare NS.

Brain Res. 2023 Sep 1;1814:148449. doi: 10.1016/j.brainres.2023.148449. Epub 2023 Jun 9.

Disparity in the use of Alzheimer's disease treatment in Southern Brazil

De Marco M, Brandi AL, Bieger A, Krug B, Camozzato A, Picon PD, Chaves MLF, Castilhos RM.

Sci Rep. 2023 Jun 12;13(1):9555. doi: 10.1038/s41598-023-36604-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias